Clinical Trial Starts for Biopharma's Antifungal in Cryptococcal Meningitis

Research Report
  ()
The details of this study and a second one are outlined in a ROTH Capital Partners report. read more >

Dermira's Phase 2b Atopic Dermatitis Trial Results Send Shares 25% Higher

  ()
Dermira shares traded higher after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference. read more >

Protalix Shares Trade up 70% Upon Release of Phase 3 Fabry Disease Data

  ()
Shares of Protalix Biotherapeutics skyrocketed on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease. read more >

Assembly Biosciences Stock Sizzles Following Phase 2a Announcement and Buy Rating from Mizuho

  ()
Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close. read more >

Achillion Pharma Shares Open 75% Higher After Alexion Buyout Offer

  ()
Shares of Achillion Pharmaceuticals traded much higher after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specific clinical trial and regulatory milestones are met. read more >
News Update

Healthcare Tech Firm Signs Five New Clients in Texas

News Update
  ()
The company just landed another five clients in Texas and now plans to build out sales teams in five additional states. read more >
News Update

Healthcare Company to Use IBM's Watson AI in Telemedicine App

News Update
  ()
The goal is to reduce the time healthcare workers spend on mundane tasks and thereby improve patient care. read more >

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results

  ()
Shares of Relmada Therapeutics traded wildly after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100200% higher and the stock was halted several times trading due to extreme price volatility. read more >

Technical Analyst Expects Health Technologies Firm to Break Higher

Contributed Opinion
  ()
Technical analyst Clive Maund outlines the reasons this stock might break higher. read more >

Cerecor Shares Rise 13% on Sale of Pediatric Portfolio for $32 Million

  ()
Shares of Cerecor Inc. traded higher after reporting that it will sell its pediatric portfolio to Aytu BioScience for $32 million in a combination cash and stock deal. read more >

Expert Investing Ideas

"DRRX earned a $10M milestone payment from Gilead."

–Ed Arce, H.C. Wainwright & Co.


"The market for DRRX's POSIMIR could be substantial."

–Brian Marckx, Zacks Small-Cap Research


"DRRX's current valuation is an interesting buying opportunity."

–Francois Brisebois, Laidlaw & Company


Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

Technical Analyst: As Antibiotic Resistance Rises, So May the Stock of This Livestock Feed Company

Contributed Opinion
  ()
Technical analyst Clive Maund believes this stock could gain traction soon. read more >

Reata Pharma Shares Trading Higher After Reacquiring U.S. and Worldwide Licensing Rights

  ()
Shares of Reata Pharmaceuticals traded 12% higher after the firm announced it had reacquired all licensing rights in the U.S. for bardoxolone methyl and worldwide rights for omaveloxolone and other next-generation Nrf2 activators from AbbVie. read more >

Ra Pharmaceuticals Shares Up 100% Following $2.1 Billion Takeover Bid

  ()
Shares of Ra Pharmaceuticals doubled after the firm announced that it will be acquired by Belgian firm UCB for $48 per share in an all cash deal. read more >

Soliton Shares Rise on Announcement It Will Report Clinical Data at National Dermatology Conference

  ()
Soliton Inc. shares traded 10% higher after advising that later this month it will present the data from clinical trials for its Rapid Acoustic Pulse device used in the treatment of keloid and hypertrophic scars at the American Society for Dermatologic Surgery Annual Meeting. read more >